HPGC Renmintongtai Pharmaceutical Corporation announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 5,700.749 million compared to CNY 6,177.849 million a year ago. Operating income was CNY 191.071 million compared to CNY 280.314 million a year ago. Net income was CNY 140.735 million compared to CNY 209.399 million a year ago. Basic earnings per share from continuing operations was CNY 0.2427 compared to CNY 0.3611 a year ago.